Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts


Euro Breast Cancer Summit 2019

On behalf of Conferences Series we welcome all the cancer researchers and the oncologists across the globe to attend the Euro Breast Cancer Summit (Euro Breast Cancer 2019) scheduled during March 20- 21, 2019 at Paris, France.

Our Europe Breast Cancer Conferences are composed of well-organized scientific sessions, Plenary presentations, Keynote speeches, Breast Cancer Expert Meetings, Oral presentations, Poster Presentations, e-Poster Presentation, Industrial Presentations, Panel Discussions, B2B Meetings, Young Researcher Forums (YRF), International workshops, Exhibitor PresentationsSponsor interactions, International Symposiums etc. The Euro Breast Cancer Summit is an international podium, which encourages the young researchers by felicitating them with the Young Researcher/ Young Scientist awards. 

This International Breast Cancer Conference provides the Cancer Researchers an exposure to the newest developments & cutting edge research in the arena of Breast Cancer and related fields. This Breast Cancer Summit 2019, Paris provides a common and unique platform, where Cancer experts from both the Industry and Academia can network with each other to promote the Collaborative research in the Breast Cancer segment and can find a cure to this disease.

Oncology Conferences | Paris Meetings | France Meetings Europe Conferences | Euro Breast Cancer Summit 2019 Conference Series

Who Should attend & Why

Who should attend Euro Breast cancer Conference 2019


All the oncologists, researchers, doctors and the interested participants who are interested in the field of breast cancer and finding the cure of Breast diseases are welcomed to exchange their knowledge and views. Target audiences includes:

·         Radiologists

 ·        Breast Imaging Technologists

·         Radiation Oncologists

·         Oncologists

·         Surgeons

·         Pathologists

·         Epidemiologists

Why attend Euro Breast Cancer Summit 2019

We are glad to invite all the interested audience to share their research and views in the  Euro Breast Cancer Summit 2019, scheduled during March 20, 21, 2019 at Paris, France. Breast Cancer is one of the major causes for the death of the population. Breast Cancer Summit 2019 is going to be podium for the Breast diseases as well as on Women’s Health. It aims to focuses on recent and forthcoming trends, new innovations among speakers,  young researchers, and workshops. Euro Breast Cancer meeting 2019 will be organized with theme “Re-Discovering Novel Approaches towards Cure for Breast Cancer & Women's Health”.

Breast Cancer is one of the most deadly disease in which many people are losing their lives and to overcome it this Cancer Therapy Conference is going to be organized to reach the maximum number of participants from the community dealing with cancer therapy. Oncology Conference, Oncology Workshop, Breast Cancer Conference. This conference includes oral and poster presentations make a splash with new drug developments, and receive name recognition at this 2 days event. Speakers across the globe, the most recent therapeutic and diagnostic techniques, developments, the novel technologies and therapeutic measures for cancer treatment and control are trademark of this conference. Euro Breast Cancer Summit 2018 provides a global platform for exchanging ideas and makes us updated about the latest technologies in the field of Breast Cancer and Women’s Health. Abstract which is going to be accepted by our peer review committee will be published in Journal of Breast Cancer and Cancer and provided with DOI. Global networking: In transferring and exchanging Ideas. Best poster presentations and young Scientist Awards.


  • Cancer Biologists
  • Oncologists
  • Residents
  • Pathologists
  • Nurses
  • Director
  • Medical Devices Companies
  • Cancer Associations/ Societies

Sessions on Breast Cancer

Track 1: Breast cancer

Breast cancer is one of the most common cancer in women as per the Centres for Disease Control and Prevention (CDC), In 2015 as per the statistics of the American Cancer Society (ACS), around 232,000 cases of were diagnosed in the United States. Cancer which spread from ducts or glands to other parts of the breast is known as invasive breast cancer. It can also be diagnosed in men. In 2015, 440 men were died and more than 2,000 men would be diagnosed with this cancer.

Track 2: Elements for developing Breast Cancer  : In female the elements for developing breast includes obesity, lack of physical exercise, drinking alcohol, hormone replacement therapy during menopause, ionized radiation, early age at first menstruation, having children late or not at all and family history. It usually develops from the lining of milk ducts and the lobules that supply the ducts with milk.

Track 3: Symptoms:-

  • A lump in breast.
  • Swelling in a particular part or whole part of the breast.
  • Breast pain.
  • Inverted nipple
  • Sudden changes in the shape and size of breast
  • Swelling or a lump under the arm
  • Blood discharge from the nipple
  • Pitted, red skin over the breast
  • discharge in Nipple other than breast milk
  • changes in the appearance of screen of the breast

Track 4: Stages of Breast Cancer: In order to determine the stages of breast cancer one should need to know the following features:

  • if the cancer is incursive or non-incursive
  • size of the tumour
  • cancer spreads  to the nearby tissues or organs
  • Involvement of lymph nodes.

Breast cancer is divided into 5 stages.

Stage 0: It is DCIS (Ductal carcinoma in situ) i.e., cancerous cells do not spread beyond the milk duct and confined in a particular place. In this stage as per the National Cancer Institute the 5-year survival rates of the patients are 100%.

Stage 1: In this stage the cancerous cells are free to attack any healthy tissue and are categorised into two parts:

  • Stage 1A: It means that the tumour cells are spread into the fat breast tissue and is no larger than a peanut shell i.e., 2cm or less and the lymph node is not affected.
  • Stage 1B: The size of the tumour is less than 2cm and it is found in few lymph nodes.

           In this stage the 5-year survival rates of the patients are also 100%.

Stage 2: The cancerous cells have grown and spread and the survival rate stage as per the National Cancer Institute for 5-year is 93%. It is divided into two parts:-

  • Stage 2A: The tumour size is between 2cm-5cm and has not spread in any lymph nodes or it is less than 2cm and has spread to 1-3 lymph nodes.
  • Stage 2B: The tumour is larger than 5 cm and has not spread to any lymph nodes or it is between 2 and 5 cm and has spread to 1–3 axillary lymph nodes.

Stage 3: The cancerous cell has not spread to bones or any organs but it is considered as advanced and harder to fight. As per the National Cancer Institute the 5-year survival rates of the patients are 72% and are categorized into 3 stages:

  • Stage 3A: The cancer has spread to 4–9 axillary lymph nodes or has enlarged the internal mammary lymph nodes, and the primary tumour can be any size. The tumour cells are larger than 5cm and small groups of these cells are found in the lymph nodes. Sometimes it is spread to 1–3 axillary lymph nodes or any breast bone nodes.


  • Stage 3B: A tumour has invaded the chest wall or skin and may or may not have invaded up to 9 lymph nodes
  • Stage 3C: Tumour is found in 10 or more axillary lymph nodes near the collar bone, or internal mammary nodes.

Stage 4: Tumour can be of any size and its cells can spread to as distant organs and distant lymph nodes. In this stage the 5-year survival rates of the patients are also 22%.

Oncology Market Analysis

To Collaborate Scientific Professionals around the World

Conference Date March 20-21, 2019

Speaker Opportunity

Past Conference Report

Supported By

Breast Cancer: Current Research Journal of Cancer Science & Therapy Archives in Cancer Research

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by